Delivery Order SPE2DR25D1103-SPE2DR26FE317
Award Date 12/11/25
Potential Completion Date 12/12/25
Potential Value $9.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $9,713.53 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a pediatric formulation of the widely-used GLP-1 receptor agonist for weight management. The contract carries no set-aside designation, indicating it was competitively awarded through AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $8,851.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections on September 26, 2025, with completion by September 29, 2025. The contract was competitively awarded with no set-aside designation and is based in Conshohocken, Pennsylvania. This delivery order represents a pediatric formulation of the diabetes and weight management medication and falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $35,903.76 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 ml pen injectors. This firm fixed-price contract, with an ultimate completion date of October 28, 2025, represents a pediatric formulation delivery supporting federal medical supply needs. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pre-filled pens valued at $5,398.78. This is a firm fixed price delivery order with an ultimate completion date of December 9, 2025, issued under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a $3,330.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. The contract is scheduled for completion by December 2, 2025, with performance to take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's established capability to meet federal...
- The Defense Logistics Agency awarded a $21,121.26 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric formulation of semaglutide, a glucagon-like peptide-1 receptor agonist used for chronic weight management. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $29,966.73 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pens (semaglutide injection). This is a firm fixed-price, non-set-aside contract with a completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $13,438.83 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens (semaglutide injection). The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by November 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,838.51 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed-price delivery order represents a pediatric or lower-dose formulation of semaglutide used in diabetes management and is being delivered to the company's headquarters location in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $25,598.30 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens on August 29, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition...